Nos publications
Mise à jour novembre 2023
Pagination
- Page précédente
- Page 38
- Page suivante
Title Trier par ordre croissant | Authors | Year | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
C-reactive protein enhances murine antibody-mediated transfusion-related acute lung injury | Kapur R, Kim M, Shanmugabhavananthan S, Liu J, Li Y, Semple JW | 2015 | Blood | View C-reactive protein enhances murine antibody-mediated transfusion-related acute lung injury | Researchers | Basic research |
c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance | Li F, Xiong Y, Yang M, Chen P, Zhang J, Wang Q, Xu M, Wang Y, He Z, Zhao X, Huang J, Gu X, Zhang L, Sun R, Sun X, Li J, Ou J, Xu T, Huang X, Cao Y, Xu XR, Karakas D, Li J, Ni H, Zhang Q | 2022 | Cell Death Dis | View c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance | Researchers | Basic research |
Buffy coat platelets coming to America: Are we ready? | Gammon RR, Devine D, Katz LM, Quinley E, Wu Y, Rowe K, Razatos A, Min K, Reichenberg S, Smith R | 2021 | Transfusion | View Buffy coat platelets coming to America: Are we ready? | Blood operators | New or improved product or process |
Buffy coat (top/bottom)- and whole-blood filtration (top/top)-produced red cell concentrates differ in size of extracellular vesicles | Bicalho B, Pereira AS, Acker JP | 2015 | Vox Sang | View Buffy coat (top/bottom)- and whole-blood filtration (top/top)-produced red cell concentrates differ in size of extracellular vesicles | Researchers | Basic research |
BSH guidelines for the use of irradiated blood components: guidance that is needed | Shehata N | 2020 | Br J Haematol | View BSH guidelines for the use of irradiated blood components: guidance that is needed | Health care providers | Benchmarking and standard setting |
Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation | Tseng E, Crowther MA, Hillis CM | 2016 | CMAJ | View Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation | Health care providers | Clinical research |
Bonnes pratiques en matière de transfusion de plaquettes | Romans R | 2019 | Blood.ca website | View Bonnes pratiques en matière de transfusion de plaquettes | Health care providers | Benchmarking and standard setting |
Blood: the basics | Chargé S, Hodgkinson KM | 2017 | Blood.ca website | View Blood: the basics | Health care providers | Other |
Blood-Borne Pathogens - A Canadian Blood Services Centre for Innovation Symposium | Walsh GM, Shih AW, Solh Z, Golder M, Schubert P, Fearon M, Sheffield WP | 2016 | Transfus Med Rev | View Blood-Borne Pathogens - A Canadian Blood Services Centre for Innovation Symposium | Health care providers | Other |
Blood unit segments accurately represent the biophysical properties of red blood cells in blood bags but not hemolysis | Islamzada E, Matthews K, Lamoureux E, Duffy SP, Scott MD, Ma H | 2022 | Transfusion | View Blood unit segments accurately represent the biophysical properties of red blood cells in blood bags but not hemolysis | Researchers | Basic research |
Blood System Inventory Management Best Practices Guide | Clarke G, Romans R | 2020 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID-19 pandemic | Prokopchuk-Gauk O, Petraszko T, Nahirniak S, Doncaster C, Levy I | 2021 | Transfusion | View Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID-19 pandemic | Regulators | Benchmarking and standard setting |
Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity of red blood cell products and charactersitics of extracellular vesicles. | Almizraq RJ, Norris PJ, Inglis H, Menocha S, Wirtz MR, Juffermans N, Pandey S, Spinella PC, Acker JP, Muszynski JA | 2018 | Blood Adv | View Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity of red blood cell products and charactersitics of extracellular vesicles. | Researchers | Basic research |
Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study | Jackson Chornenki NL, James TE, Barty R, Liu Y, Rochwerg B, Heddle NM, Siegal DM | 2020 | Transfusion | View Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study | Health care providers | Clinical research |
Blood is a politic of place-making: Blackness, queerness and the construction of the donor | Dryden OH | 2022 | Harriet’s Legacies: Race, Historical Memory, and Futures in Canada | View Blood is a politic of place-making: Blackness, queerness and the construction of the donor | Researchers | MSM research |
Blood groups and susceptibility to virus infection: new developments | Branch DR | 2010 | Curr Opin Hematol | View Blood groups and susceptibility to virus infection: new developments | Researchers | Basic research |
Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study | Delaney M, Wikman A, van de Watering L, Schonewille H, Verdoes JP, Emery SP, Murphy MF, Staves J, Flach S, Arnold DM, Kaufman RM, Ziman A, Harm SK, Fung M, Eppes CS, Dunbar NM, Buser A, Meyer E, Savoia H, Abeysinghe P, Heddle N, Tinmouth A, Traore AN, Yazer MH, for the Best Collaborative | 2017 | Transfusion | View Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study | Researchers | Clinical research |
Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors | Saw CL, Hannach B, Petrazsko T, Nickerson P | 2013 | Transfusion | View Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors | Researchers | Clinical research |
Blood donors | Armstrong B, Reviewer for Second Edition: Goldman M | 2020 | ISBT Sci Ser | View Blood donors | Health care providers | Benchmarking and standard setting |
Blood donor eligibility criteria for medical conditions: A BEST collaborative study | Jacquot C, Tiberghien P, van den Hurk K, Ziman A, Shaz B, Apelseth TO, Goldman M, The Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Vox Sang | View Blood donor eligibility criteria for medical conditions: A BEST collaborative study | Researchers | Benchmarking and standard setting |
Blood donor characteristics on transfusion outcomes-should obesity be assessed in future clinical trials?-reply | Chasse M, Fergusson DA | 2017 | JAMA Intern Med | View Blood donor characteristics on transfusion outcomes-should obesity be assessed in future clinical trials?-reply | Researchers | Clinical research |
Blood donation testing and the safety of the blood supply | Goldman M | 2017 | Practical Transfusion Medicine, 5th Edition | View Blood donation testing and the safety of the blood supply | Health care providers | Benchmarking and standard setting |
Blood Donation Testing and the Safety of the Blood Supply | Goldman M, Drews SJ | 2022 | Practical Transfusion Medicine | View Blood Donation Testing and the Safety of the Blood Supply | Health care providers | Benchmarking and standard setting |
Blood donation and the global COVID-19 pandemic: areas for social science research | Haw J, Holloway K, Masser B, Merz E-M, Thrope R | 2020 | Vox Sang | View Blood donation and the global COVID-19 pandemic: areas for social science research | Researchers | New or improved product or process |
Blood donation and testosterone replacement therapy | Chin-Yee B, Lazo-Langner A, Butler-Foster T, Hsia C, Chin-Yee I | 2017 | Transfusion | View Blood donation and testosterone replacement therapy | Health care providers | Clinical research |
Blood components | Clarke G | 2017 | Clinical Guide to Transfusion | View Blood components | Health care providers | Benchmarking and standard setting |
Blood Components | Gupta A, Bigham M | 2020 | Clinical Guide to Transfusion | View Blood Components | Health care providers | Benchmarking and standard setting |
Blood component transfusion in critically ill patients | McIntyre L, Tinmouth AT, Fergusson DA | 2013 | Curr Opin Crit Care | View Blood component transfusion in critically ill patients | Health care providers | Clinical research |
Blood Collection Agency Messaging to Donors and the Public in Canada and Australia During the Early Days of COVID-19 | Haw J, Thorpe R, Holloway K | 2022 | Front Commun | View Blood Collection Agency Messaging to Donors and the Public in Canada and Australia During the Early Days of COVID-19 | Blood operators | Ethical, legal and social implications research |
Blood collection | Armstrong B, Reviewer for Second Edition: Goldman M | 2020 | ISBT Sci Ser | View Blood collection | Health care providers | Benchmarking and standard setting |
Blood coagulation dissected | Pryzdial ELG, Lee FMH, Lin BH, Carter RLR, Tegegn TZ, Belletrutti MJ | 2018 | Transfus Apher Sci | View Blood coagulation dissected | Health care providers | Other |
Blood bank storage of red blood cells increases RBC cytoplasmic membrane order and bending rigidity | Himbert S, Qadri SM, Sheffield WP, Schubert P, D’Alessandro A, Rheinstädter MC | 2021 | PLoS One | View Blood bank storage of red blood cells increases RBC cytoplasmic membrane order and bending rigidity | Researchers | Basic research |
Blood bag spiking procedure | Shimla S, Jenkins C, McTaggart K | 2018 | Blood.ca website | View Blood bag spiking procedure | Other | Other |
Blood bag plasticizers influence red blood cell vesiculation rate without altering the lipid composition of the vesicles | Bicalho B, Serrano K, dos Santos Pereira A, Devine D, Acker J | 2016 | Transfus Med Hemother | View Blood bag plasticizers influence red blood cell vesiculation rate without altering the lipid composition of the vesicles | Researchers | Basic research |
Blood and clots series: Which antithrombotic therapy should I start for my patient with acute VTE? | Tseng E | 2018 | CanadiEM website | View Blood and clots series: Which antithrombotic therapy should I start for my patient with acute VTE? | Health care providers | Benchmarking and standard setting |
Blood and clots series: What are the risks of reversing DOAC-associated intracranial bleeding? | Shih A | 2018 | CanadiEM website | View Blood and clots series: What are the risks of reversing DOAC-associated intracranial bleeding? | Health care providers | Benchmarking and standard setting |
Blood and clots series: My patient has a pulmonary embolism. Should I screen them for cancer? | Tseng E | 2018 | CanadiEM website | View Blood and clots series: My patient has a pulmonary embolism. Should I screen them for cancer? | Health care providers | Benchmarking and standard setting |
Blood and clots series: How can I tell whether this patient has a deep vein thrombosis? | de Wit K | 2018 | CanadiEM website | View Blood and clots series: How can I tell whether this patient has a deep vein thrombosis? | Health care providers | Benchmarking and standard setting |
Blood and clots quizlet 5: Should I screen my patient for occult cancer after unprovoked VTE? | Tseng E, Shih A, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 5: Should I screen my patient for occult cancer after unprovoked VTE? | Health care providers | Benchmarking and standard setting |
Blood and clots quizlet 4: Antithrombotic Therapy for Atrial Fibrillation | Tseng E, Shih A, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 4: Antithrombotic Therapy for Atrial Fibrillation | Health care providers | Benchmarking and standard setting |
Blood and clots quizlet 3: Procedures on warfarin | Tseng E, Shih A, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 3: Procedures on warfarin | Health care providers | Benchmarking and standard setting |
Blood and clots quizlet 2: Trauma in a patient on warfarin | Shih A, Tseng E, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 2: Trauma in a patient on warfarin | Health care providers | Benchmarking and standard setting |
Blood and clots quizlet 1: Oral contraceptives and pulmonary embolism | Tseng E, Yeh C, Shih A, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 1: Oral contraceptives and pulmonary embolism | Health care providers | Benchmarking and standard setting |
Blood Administration | de Biasio L, Rymer T | 2017 | Clinical Guide to Transfusion | View Blood Administration | Health care providers | Other |
Blood Administration | O'Reilly C | 2020 | Clinical Guide to Transfusion | View Blood Administration | Health care providers | Benchmarking and standard setting |
Bleeding complications in immune thrombocytopenia | Arnold DM | 2015 | Hematology Am Soc Hematol Educ Program | View Bleeding complications in immune thrombocytopenia | Health care providers | Clinical research |
Bleeding complications from the direct oral anticoagulants | Sholzberg M, Pavenski K, Shehata N, Cserti-Gazdewich C, Lin Y | 2015 | BMC Hematol | View Bleeding complications from the direct oral anticoagulants | Health care providers | Clinical research |
BK virus prophylaxis with levofloxacin--reply | Gill JS, Knoll GA, Humar A | 2015 | JAMA | View BK virus prophylaxis with levofloxacin--reply | Other | Other |
Bioorthogonal phase-directed copper-catalyzed azide–alkyne cycloaddition (PDCuAAC) coupling of selectively cross-linked superoxide dismutase dimers produces a fully active bis-dimer | Siren EM, Singh S, Kluger R | 2015 | Org Biomol Chem | View Bioorthogonal phase-directed copper-catalyzed azide–alkyne cycloaddition (PDCuAAC) coupling of selectively cross-linked superoxide dismutase dimers produces a fully active bis-dimer | Researchers | Basic research |
Biomonitoring of Arsenic in Urine and Saliva of Children Playing on Playgrounds Constructed from Chromated Copper Arsenate-Treated Wood | Lew K, Acker JP, Gabos S, Le XC | 2010 | Environ Sci Technol | View Biomonitoring of Arsenic in Urine and Saliva of Children Playing on Playgrounds Constructed from Chromated Copper Arsenate-Treated Wood | Researchers | Other |